Drug News
-
Sumitomo Pharma’s ORGOVYX Receives Health Canada Approval for Advanced Prostate Cancer Treatment
MISSISSAUGA, Ontario, Oct. 23, 202— In a significant development in the field of advanced prostate cancer treatment, Sumitomo Pharma Canada,…
Read More » -
INVO Bioscience and NAYA Biosciences Announce Merger for Breakthrough Fertility and Oncology Treatments
SARASOTA, Fla. and AVENTURA, Fla., Oct. 23, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) and NAYA Biosciences Inc. have jointly…
Read More » -
Commonly Used Drug Amitriptyline Might Be New Treatment Option for IBS
By Cara Murez HealthDay Reporter An inexpensive medication long used for depression and migraines now has a clinical trial to…
Read More » -
FDA Grants Approval to UCB’s Bimzelx (bimekizumab-bkzx) for Moderate to Severe Plaque Psoriasis Treatment
UCB, a global biopharmaceutical company, has announced the approval of Bimzelx® (bimekizumab-bkzx) by the U.S. Food and Drug Administration (FDA)…
Read More » -
Sterile Dosage Form Market Anticipated to Reach US$ 1.1 Billion by 2033, Driven by Rising Demand for Infection-Free Medical Products | Future Market Insights, Inc.
The sterile dosage forms market will be valued at US$ 582.9 million in 2023. The market is anticipated to grow at a 6.7% CAGR throughout the…
Read More » -
Cholangiocarcinoma Market Growth Projection 2019 to 2032 By DelveInsight
DelveInsight, a leading market intelligence and analytics firm, has unveiled its comprehensive report on the Cholangiocarcinoma market. This report provides…
Read More » -
Doxorubicin Market Expected to Grow by USD 469.97 Million from 2022 to 2027, with North America Leading the Way – Technavio
The doxorubicin market is poised for substantial expansion over the coming years, with a projected increase of USD 469.97 million…
Read More » -
Boehringer Ingelheim India and PPAM Collaborate to Raise Rabies Awareness in Mumbai Schools
Mumbai, India — Boehringer Ingelheim India, in partnership with the Pet Practitioners Association of Mumbai (PPAM), has taken a significant…
Read More » -
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
Ardelyx, Inc., a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medical solutions, announced that the U.S. Food and…
Read More » -
Aculys Pharma Announces Positive Phase 3 Interim Analysis Results for Diazepam Nasal Spray in the Treatment of Epileptic Seizures
Aculys Pharma, a clinical-stage biopharmaceutical company specializing in innovative treatments for neurological conditions, has reported a significant achievement in its…
Read More »